Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases. (Q45871728)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Mendes-Madeira A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Meur GL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Weber M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Deschamps JY

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Nivard D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Provost N

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Moullier P

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Rolling F

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

4 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1668-1673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.gt.3303034

8 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Risks of intravitreous injection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Adeno-associated virus-mediated expression of vascular endothelial growth factor peptides inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Gene therapy for ocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

New uses of older antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

Regulation of rod phototransduction machinery by ciliary neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Angiogenic pathways in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

VEGF: a critical player in neurodegeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Factors influencing recombinant adeno-associated virus production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3303034

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3303034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17914405%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 January 2020

0 references

1 reference